OncoZenge AB (publ) (OM:ONCOZ) Explores Strategic Options for Bupizenge? in China. To Explore Strategic Options for Introduction of Bupizenge in China.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.87 SEK | -2.15% | -1.90% | +25.24% |
08/04 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
04/04 | OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.24% | 4.27M | |
+29.85% | 684B | |
+30.34% | 568B | |
-4.05% | 361B | |
+18.10% | 329B | |
+4.18% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.87% | 166B |
- Stock Market
- Equities
- ONCOZ Stock
- News OncoZenge AB
- Oncozenge Explores Strategic Options for Bupizeng in China